Why Dendreon's Shares Plunged
By Travis Hoium | More Articles
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Dendreon (Nasdaq: DNDN ) have fallen 13% today after competitor Johnson & Johnson (NYSE: JNJ ) reported positive results from a drug test.
So what: The trial in question is Johnson & Johnson's prostate cancer clinical trial for Zytiga, a competitor to Provenge. The successful results may put a big dent in Provenge's $82 million in quarterly sales as physicians transition to the more effective therapy and generics enter the market.
Now what: An analyst from Wedbush predicted that Provenge may be replaced completely as more effective and cheaper therapies become available for early stage prostate cancer patients. He was already bearish in the stock but cut his price target to $4 from $5, not a good sign for investors. I don't see a reason to buy the dip today since Dendreon was already losing money even before this blow to its future results.
- Forums
- ASX - By Stock
- IMM
- where is pbmd place
where is pbmd place
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 388130 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 39940 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 388130 | 0.295 |
8 | 134112 | 0.290 |
8 | 159211 | 0.285 |
15 | 235396 | 0.280 |
7 | 214272 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 39940 | 3 |
0.305 | 116791 | 7 |
0.310 | 295779 | 7 |
0.315 | 160007 | 6 |
0.320 | 130000 | 3 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |